Publication: Protruding structures with high expression of LGR5 are formed during regrowth phase after chemo-treatment in xenograft model of colorectal adenocarcinoma
Authors
Yamazaki, Masaki ; Kato, Atsuhiko ; Sawada, Noriaki ; Watanabe, Takeshi ; Suzuki, Masami
item.page.secondaryauthor
item.page.director
Publisher
Universidad de Murcia, Departamento de Biologia Celular e Histiologia
publication.page.editor
publication.page.department
DOI
https://doi.org/10.14670/HH-18-374
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Recurrence after chemotherapy is one of the
biggest obstacles in cancer therapy, along with
metastasis. Although histopathological evaluation in
preclinical models like the xenograft model help us to
understand the pathophysiological process of tumor
growth, there are not enough detailed histopathological
analyses of such models. In this study, to learn how a
tumor recovers the typical tumor structure after
structural corruption during chemo-treatment,
xenografted tumors originating from a patient-derived
xenograft of colorectal cancer (CRC) were analyzed
histopathologically over time. There were many Duct
(Flattened) at Day 1 (one day after the final
administration of Irinotecan), but the ratio of Duct
(Columnar) and Cribriform—structures typically found
in colorectal adenocarcinoma—increased over time.
Finally, at Day 15 (15 days after the final administration
of Irinotecan), tumor structure and size were once again
the same as in the control group. LGR5, a known cancer
stem cell (CSC) marker for CRC, was highly expressed
on protruding structures observed from Duct (Flattened)
during their transformation into Duct (Columnar) and
Cribriform. In addition, these LGR5-expressing
protruding structures were either Ki67 negative or
positive. These results suggest that the formation of
protruding structures on Duct (Flattened) is a pivotal
first step in the regrowth of tumors
publication.page.subject
Citation
Histology and Histopathology Vol. 37, nº1 (2022)
item.page.embargo
Ir a EstadÃsticas
Este Ãtem está sujeto a una licencia Creative Commons. http://creativecommons.org/licenses/by-nc-nd/4.0/